| News
Bayer is growing in Basel
26.06.2017
The German life sciences company Bayer wants to continue to grow in Basel, as company representatives announced in a press conference. Bayer settled in Basel in 2005. Since then, the number of employees has risen from 120 to 750. For the coming years, the group expects 100 additional employees per year. The workforce includes people from 60 nations.

Bayer. (Img: Bayer AG)
Of the 750 employees, 500 work in the Consumer Health sector, which includes non-prescription drugs such as aspirin, bepanthen or Alka-Seltzer. Since 2016, Basel is the global headquarter of this division. In addition, parts of Bayer’s pharmaceutical division are also operating from Basel. These include employees in the fields of oncology, ophthalmology and hematology. These departments recorded the largest increase in new employees.
According to Bayer, the company can chose from 7,000 applications per year. The Group benefits from the Basel Life Sciences Cluster as well as its proximity to pharmaceutical giants like Roche and Novartis.
As the company’s representatives stated, Basel’s location is not more expensive than others, but more attractive. And since employees in Basel could gain extensive experience within a short time, the location works like a talent hub for the entire group. In order to adjust to the growth, the company invested 20 million Swiss francs in the reconstruction of its office space in the Peter Merian building in Basel.
Bayer is also located in the Infrapark Baselland with an offshoot of its agrochemical division. Bepanthen is produced in Grenzach-Wyhlen. With more locations in Zurich and Zollikofen, Bayer employs more than 1200 people in Switzerland, 115’200 worldwide. In 2016, the company had a turnover of 46.8 Euro billion.
Share this article
Sign up to receive our newsletter in your inbox.
You might also be interested in
Clinerion is now part of Citeline
Clinerion has been integrated into New York-based company Citeline. Clinerion plans to expand its portfolio with Citeline’s complementary opportunities with...
Read MoreKUORI developing biodegradable plastics
The Basel-based cleantech company KUORI GmbH develops alternative materials for conventional plastics. The aim is to reduce the accumulation of...
Read MoreCell and gene therapies gain momentum in Basel
Companies specializing in the research and development of innovative cell and gene therapies continue to spring up all around the...
Read MoreBLKB expanding support for startups
BLKB offers particularly promising SMEs and startups financial support within the framework of the “100 fürs Baselbiet” program. These companies...
Read MoreCombatting the rise of antimicrobial resistance
Antimicrobial resistance (AMR) is a growing global threat that, without intervention, could lead to as many as 10 million deaths...
Read MoreAMR Action Fund invests in new antibiotics developed by BioVersys
The AMR Action Fund has made its first European investment in BioVersys, which is headquartered at Tech Park Basel. The...
Read MoreInvestors give Resistell 8.5 million Swiss francs
Resistell AG has secured 8.5 million Swiss francs in the first part of its series B funding round. The biotechnology...
Read MoreBSI integrating AI from Parashift in banking software
Parashift, the specialist in the area of smart document processing on the basis of Artificial Intelligence (AI), has entered into...
Read MoreUptownBasel joins IBM Quantum Network
UptownBasel is partnering with IBM. The emerging competence center for Industry 4.0 will provide its partners with the IBM Quantum...
Read MoreSouth Korean pharma firms show interest in the Basel Area
Several South Korean firms from the life sciences industry, including three pharmaceutical multinationals, have visited the Basel Area on fact-finding...
Read More